'Gain of function' phenotype of tumor-derived mutant p53 requires the oligomerization/nonsequence-specific nucleic acid-binding domain

Oncogene

Volumn 16, Issue 24, 1998, Pages 3169-3176

  Lányi, Árpád ^a   Deb, Debabrita ^a   Seymour, Robert C ^a   Ludes Meyers, John H ^a   Subler, Mark A ^a   Deb, Sumitra ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Mutant p53; Transcriptional activation, domain

Indexed keywords

CYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR; MUTANT PROTEIN; PROTEIN P53;

ANIMAL CELL; ARTICLE; CARCINOGENICITY; DELETION MUTANT; MOUSE; NONHUMAN; OLIGOMERIZATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DNA BINDING; TRANSACTIVATION;

ANIMALIA; MURINAE; MUS MUSCULUS;

EID: 0032543718     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201857     Document Type: Article

References (47)

1. Bargonetti J, Manfredi J. Chen X, Marshak DR and Prives C. (1993). Genes Dev., 7, 2565-2574.
2. Chen CJ, Clark D, Ueda K, Pastan I, Gottesman MM and Robinson IB. (1990). J. Biol. Chem., 265, 506-514.
3. Chin K-V, Ueda K, Pastan I and Gottesman MM. (1992). Science, 255, 459-462.
4. Cho Y, Gorina S, Jeffrey PD and Pavletich NP. (1994). Science, 265, 346-355.
5. Clore GM, Omichiniski JG, Sakaguchi K, Sakamoto H, Appella E and Gronenborn AM. (1994). Science, 265, 386-391.
6. Deb S, Jackson CT, Subler MA and Martin DW. (1992). J. Virol., 66, 6164-6170.
7. Deb SP, Muñoz RM, Brown DR, Subler MA and Deb S. (1994). Oncogene, 9, 1341-1350.
8. Dittmer D, Pati S, Zambetti GS, Chu S, Teresky A, Moore M, Finlay C and Levine AJ. (1993). Nature Genetics, 4, 42-46.
9. Donehower LA and Bradley A. (1993). Biochim. Biophys. Acta, 1155, 185-205.
10. Fields S and Jang SK. (1990). Science, 249, 1046-1049.
11. Ginsberg D, Mechta F, Yaniv M and Oren M. (1991). Proc. Natl. Acad. Sci. USA, 88, 9979-9983.
12. Greenblatt MS, Bennet WP, Hollstein M and Harris CC. (1994). Cancer Res., 54, 4855-4878.
13. Gruda MC, Zabolotny JM, Xiao JH, Davidson I and Alwine C. (1993). Mol. Cell. Biol., 13, 961-969.
14. Halazonetis TD and Kandil AN. (1993). EMBO J., 12, 5057-5064.
15. Harvey D and Levine AJ. (1991). Genes and Develop., 5, 2375-2385.
16. Hinds PW, Finlay CA, Quartin RS, Baker SJ, Fearon ER, Vogelstein B and Levine AJ. (1990). Cell Growth Differ., 1, 571-580.
17. Hollstein M, Sidransky D, Vogelstein B and Harris CC. (1991). Science, 253, 49-53.
18. Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sorlie T, Hovig E, Smith-Sorensen B, Montesano R and Harris CC. (1994). Nucleic Acids Res., 22, 3551-3555.
19. Hsiao M, Low J, Dorn E, Ku D, Pattengale P, Yeargin J and Haas M. (1994). Am. J. Pathol., 145, 702-714.
20. Kieser A, Weich HA, Brandner G, Marme D and Kolch W. (1994). Oncosene, 9, 963-969.
21. Ko LJ and Prives C. (1996). Genes Develop., 10, 1054-1072.
22. Lane DP. (1994). Br. Med. Bull., 5, 582-599.
23. Lechner MS, Mack DH, Fincle AB, Crook T, Vousden KH and Laiminis LA. (1992). EMBO J., 11, 3045-3052.
24. Lee W, Harvey TS, Yin Y, Yau P, Litchfield D and Arrowsmith CA. (1994). Struct. Biol. 1, 877-890.
25. Levine AJ, Momand J and Finlay CA. (1991). Nature, 351, 453-456.
26. Levine AJ. (1997). Cell, 88, 323-331.
27. Lin J, Teresky AK and Levine AJ. (1995). Oncogene, 10, 2387-2390.
28. Ludes-Meyers JH, Subler MA, Shivakumar CV, Munoz RM, Jiang P, Bigger JE, Brown DR, Deb SP and Deb S. (1996). Mol. Cell. Biol., 16, 6009-6019.
29. Marguiles L and Seghal PB. (1993). J. Biol. Chem., 268, 15096-15100.
30. Mueller BF, Paulsen D and Deppert W. (1996). Oncogene, 12, 1941-1952.
31. O'Rourke RW, Miller CW, Kato GJ, Simon KJ, Chen D-L, Dang CV and Koelller HP. (1990). Oncogene, 5, 1829-1832.
32. Ozbun MA and Butel JS. (1995). Ann. Cancer Res., 66, 71-141.
33. Pavletich NP, Chambers KA and Pabo CO. (1993). Genes Dev., 7, 2556-2564.
34. Raycroft L, Wu H and Lozano G. (1990). Science, 249, 1049-1051.
35. Santhanam V, Ray A and Sehgal P. (1991). Proc. Natl. Acad. Sci. USA, 88, 7605-7609.
36. Shaluski G, Goldlinger N and Rotter V. (1991). Cancer Res., 51, 5232-5237.
37. Soussi T, de Fromentel CC and May P. (1990). Oncogene, 5, 945-952.
38. Sturzbecher H-W, Brian R, Addison C, Rudge K, Remm M, Grimaldi M, Keenan E and Jenkins JR. (1992). Oncogene, 7, 1513-1523.
39. Subler MA, Martin DW and Deb S. (1992). J. Virol., 66, 4757-4762.
40. Subler MA, Martin DW and Deb S. (1994a). Oncogene, 9, 1351-1359.
41. Subler MA, Martin DW and Deb S. (1994b). J. Virol., 68, 103-110.
42. Tsutsumi-Ishi Y, Tadokoro A, Hanaoka F and Tsuchida N. (1995). Cell Growth Differ., 6, 1-8.
43. Ueha T, Nosaka T, Takahashi JA, Shibata F, Florkiewicz RZ, Vogelstein B, Oda Y, Kikuchi H and Hatanaka M. (1994). Proc. Natl. Acad. Sci. USA, 91, 9009-9013.
44. Linger T, Nan MM, Segal S and Minna JD. (1992). EMBO J., 11, 1383-1390.
45. Wang Y, Reed M, Wang P, Stenger JE, Mayr G, Schwedes JF and Tegtmeyer P. (1993). Genes Dev., 7, 2575-2586.
46. Wolf D, Admon S, Oren M and Rotter V. (1984). Mol. Cell. Biol., 4, 552-558.
47. Zastawny RL, Salvino R, Chin J, Benchimol S and Ling V. (1993). Oncogene, 8, 1529-1535.